Furthermore, IF staining targeting CD206 (prominent marker of M2-like macrophages), in conjunction with IL4I1 reaffirmed substantial co-expression of IL4I1 with TAMs in clinical glioma specimens (Figure 6D). Here, IL4I1 is linked to central nervous system cancer.